
Avance Clinical – ClinicReady Case Study
By Avance ClinicalTetherex Pharmaceuticals is developing a single-cycle adenoviral vector vaccine for the treatment of Covid-19.
The treatment is designed for intranasal delivery, which is expected to provide a more efficient front-line defence against Covid-19 in airway tissues, the site of virus entry into the body. The vaccine is currently undergoing safety testing in healthy volunteers.
To read more, please download this free white paper.
